AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2023
Jul 3, 2023
32853_dirs_2023-07-03_26f6976a-253f-499a-8f91-fadc8974db76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-06-29
Reporting Person: Caligan Partners LP (10% Owner)
Reporting Person: JOHNSON DAVID EDWARD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-29 | Common Stock, $0.001 par value per share ("Common Stock") | J | 108879 | — | Disposed | 8467920 | Indirect |
| 2023-07-03 | Common Stock | J | 670466 | — | Disposed | 7797454 | Indirect |
Footnotes
F1: Represents the total number of shares of Common Stock beneficially owned by Caligan Partners LP ("Caligan") following the termination of an investment management agreement with respect to an account previously managed by Caligan.
F2: The securities reported herein are held by an affiliated fund of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
F3: This transaction represents an in-kind distribution by certain funds and accounts to which Caligan serves as the investment manager.